Genomic characteristics of deleterious BRCA1 and BRCA2 alterations and associations with baseline clinical factors in patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in TRITON2 Meeting Abstract

  

Authors:	Abida, W.; Bryce, A. H.; Vogelzang, N. J.; Amato, R. J.; Percent, I. J.; Shapiro, J. D.; McDermott, R. S.; Hussain, A.; Patnaik, A.; Petrylak, D. P.; Ryan, C. J.; Stanton, T. S.; Zhang, J.; Loehr, A.; Simmons, A.; Despain, D.; Golsorkhi, A. A.; Watkins, S. P.; Scher, H. I.; Chowdhury, S.
Abstract Title:	Genomic characteristics of deleterious BRCA1 and BRCA2 alterations and associations with baseline clinical factors in patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in TRITON2
Meeting Title:	55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	37
Issue:	15 Suppl.
Meeting Dates:	2019 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2019-05-20
Start Page:	295s
Language:	English
ACCESSION:	WOS:000487345805439
DOI:	10.1200/JCO.2019.37.15_suppl.5031
PROVIDER:	wos
Notes:	Meeting Abstract: 5031 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/156205